Hemoglobin solutions

Critical Care Medicine

Volumn 31, Issue 12 SUPPL., 2003, Pages

  Creteur, Jacques ^a   Vincent, Jean Louis ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Microcirculation; Nitric oxide; Red blood cell; Resuscitation

Indexed keywords

DIASPIRIN CROSSLINKED HEMOGLOBIN; HEMOGLOBIN; NITRIC OXIDE;

ARTICLE; BLOOD SUBSTITUTION; CELL FREE SYSTEM; CHEMICAL STRUCTURE; COMPUTER; ERYTHROCYTE TRANSFUSION; HUMAN; INJURY; INTENSIVE CARE; MEDLINE; METABOLISM; MICROCIRCULATION; OXIDATION; PARAMETER; POPULATION; PRIORITY JOURNAL; RESUSCITATION; REVIEW; TREATMENT INDICATION; UNITED STATES; VASOCONSTRICTION;

EID: 0346887087     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ccm.0000098037.40520.81     Document Type: Review

References (118)

1. Winslow RM: Blood substitutes: Refocusing an elusive goal. Br J Haematol 2000; 111: 387-396
2. Amberson WR, Jennings JJ, Rhode CM: Clinical experience with hemogobin-saline solution. J Appl Physiol 1949; 1:469-489
3. Rabiner SF, O'Brien K, Peskin GW, et al: Further studies with stroma-free hemoglobin. Ann Surg 1970; 171:615-622
4. Savitsky JP, Doczi J, Black J, et al: A clinical safety trial of stroma-free hemoglobin. Clin Pharmacol Ther 1978; 23:73-80
5. Matsushita M, Yabuki A, Malchesky PS, et al: In vivo evaluation of a pyridoxalated-hemoglobin-polyoxyethylene conjugate. Biomater Art Cells Art Organs 1988; 16: 247-260
6. 2 capacity. Surgery 1984; 95:333-338
7. Chatterjee R, Welty EV, Walder RY, et al: Isolation and characterization of a new hemoglobin derivate cross-linked between the a chains. J Biol Chem 1986; 261:9929-9937
8. 2 carrier. J Trauma 1986; 26: 903-908
9. Rabinovici R, Rudolph AS, Ligler FS, et al: Liposome-encapsulated hemoglobin: An oxygen carrying fluid. Circ Shock 1990; 32: 1-17
10. Usuba A, Motoki R, Suzuki K, et al: Study of the effect of the newly developed artificial "neo red cells" (NRC) on hemodynamics and blood gas transport in canine hemorrhagic shock. Biomater Art Cells Immob Biotech 1992; 20:531-535
11. Szebeni J, Hauser H, Eskelson CD, et al: Factors influencing the in vitro stability of artificial red blood cells based on hemoglobin-containing liposomes. Biomater Art Cells Art Organs 1988; 16:1-3
12. Chang TM: Future generations of red blood cell substitutes. J Intern Med 2003; 253: 527-535
13. Wagner PD: An integrated view of the determinants of maximum oxygen uptake. In: Oxygen Transfer from Atmosphere to Tissues. Gonzales NC, Fredde MR (Eds). New York, Plenum, 1988, pp 245-256
14. De Backer D, Creteur J, Preiser JC, et al: Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 2002; 166:98-104
15. Vlahakes GJ, Lee R, Jacobs EE, et al: Memodynamic effects and oxygen transport properties of a new blood substitute in a model of massive blood replacement. J Thorac Cardiovasc Surg 1990; 100:379-388
16. Przybelski RJ, Malcolm DS, Burris DG, et al: Cross-linked hemoglobin solution as a resuscitative fluid after hemorrhage in the rat. J Lab Clin Med 1991; 117:143-151
17. Cohn SM, Farrell TJ: Diaspirin cross-linked hemoglobin resuscitation of hemorrhage: Comparison of a blood substitute with hypertonic saline and isotonic saline. J Trauma 1994; 39:210-217
18. Lee R, Neya K, Svizzero TA, et al: Limitations of the efficacy of hemoglobin-based oxygen-carrying solutions. J Appl Physiol 1995; 79:236-242
19. Leppäniemi A, Soltero R, Burris D, et al: Early resuscitation with low-volume poly-DCLHb is effective in the treatment of shock induced by penetrating vascular injury. J Trauma 1996; 40:242-248
20. Hughes GS Jr, Antal EJ, Locker PK, et al: Physiology and pharmacokinetics of a novel hemoglobin-based oxygen carrier in humans. Crit Care Med 1996; 24:756-764
21. 2 carriers after 2h of hemorrhagic shock in conscious hamsters. Am J Physiol 1997; 272: H525-H537
22. Migita R, Gonzales A, Gonzales ML, et al: Blood volume and cardiac index in rats after exchenge transfusion with hemoglobin-based oxygen carriers. J Appl Physiol 1997; 82:1995-2002
23. Cole DJ, Drummond JC, Patel PM, et al: Effect of oncotic pressure of diaspirin cross-linked hemoglobin (DCLHb™) on brain injury after temporary focal cerebral ischemia in rats. Anesth Analg 1996; 83:342-347
24. Intaglietta M, Johnson PC, Winslow RM: Microvascular and tissue oxygen distribution. Cardiovasc Res 1996; 32:632-643
25. Kuchan MJ, Frangos JA: Shear stress regulates endothelin-1 release via protein kinase C and cGMP in cultured endothelial cells. Am J Physiol 1993; 264:H150-H156
26. Kuchan MJ, Jo H, Frangos JA: Role of G proteins in shear stress-mediated nitric oxide production by endothelial cells. Am J Physiol 1994; 267:C753-C758
27. Tsai AG, Friesenecker B, McCarthy M, et al: Plasma viscosity regulates capillary perfusion during extreme hemodilution in hamster skinfold model. Am J Physiol 1998; 275:H2170-H2180
28. Thompson A, McGarry AE, Valeri CR, et al: Stroma-free hemoglobin increases blood pressure and GFR in the hypotensive rat: Role of nitric oxide. J Appl Physiol 1994; 77:2348-2354
29. Sharma AC, Gulati A: Effect of diaspirin cross-linked hemoglobin and norepinephrine on systemic hemodynamics and regional circulation in rats. J Lab Clin Med 1994; 123:299-308
30. Sharma AC, Singh G, Gulati A: Role of NO mechanism in cardiovascular effects of diaspirin cross-linked hemoglobin in anesthetized rats. Am J Physiol 1995; 269: H1379-H1388
31. Hindman BJ, Dexter F, Cutkomp J, et al: Diaspirin cross-linked hemoglobin dos not increase brain oxygen consumption during hypothermic cardiopulmonary bypass in rabbits. Anesthesiology 1995; 83:1302-1311
32. Aranow JS, Wang H, Zhuang J, et al: Effect of human hemoglobin on systemic and regional hemodynamics in a porcine model of endotoxemic shock. Crit Care Med 1996; 24:807-814
33. Gulati A, Sharma AC, Singh G: Role of endothelin in the cardiovascular effects of diaspirin crosslinked and stroma reduced hemoglobin. Crit Care Med 1996; 24:137-147
34. Kasper SM, Grune F, Walter M, et al: The effects of increased doses of bovine hemoglobin on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery. Anesth Analg 1998; 87:284-291
35. Przybelski RJ, Daily EK, Kisicki JC, et al: Phase I study of the safety and pharmacologic effects of diaspirin cross-linked hemoglobin soltuion. Crit Care Med 1996; 24: 1993-2000
36. Reah G, Bodenham AR, Mallick A, et al: Initial evaluation of diaspirin cross-linked hemoglobin (DCLHb) as a vasopressor in critically ill patients. Crit Care Med 1997; 25:1480-1488
37. Lamy ML, Daily EK, Brichant JF, et al: Randomized trial of diaspirin cross-linked hemoglobin solution as an alternative to blood transfusion after cardiac surgery. Anesthesiology 2000; 92:646-656
38. Hill SE, Gottschalk LI, Grichnik K: Safety and preliminary efficacy of hemoglobin raffimer for patients undergoing coronary artery bypass surgery. J Cardiothorac Vasc Anesth 2002; 16:695-702
39. Levy JH, Goodnough LT, Greilich PE, et al: Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery. Results of a randomized, double-blind trial. J Thorac Cardiovasc Surg 2002; 124:35-42
40. LaMuraglia GM, O'Hara PJ, Baker WH, et al: The reduction of the allogenic transfusion requirement in aortic surgery with a hemoglobin-based solution. J Vasc Surg 2000; 31:299-308
41. Rooney MW, Hirsch LJ, Mathru M: Hemodilution with oxyhemoglobin: Mechanism of oxygen deivery and its superaugmentation with a nitric oxide donor (sodium nitroprusside). Anesthesiology 1993; 79:60-72
42. Schultz SC, Grady B, Cole F, et al: A role for endothelin and nitric oxide in the pressor response to diaspirin cross-linked hemoglobin. J Lab Clin Med 1993; 122:301-308
43. Freas W, Llave R, Jing M, et al: Contractile effects of diaspirin cross-linked hemoglobin (DCLHb TM) on isolated porcine blood vessels. J Lab Clin Med 1995; 125:762-767
44. Ulatowski JA, Nishikawa T, Matheson-Urbaitis B, et al: Regional blood flow alterations after bovine fumaryl ββ-crosslinked hemoglobin transfusion and nitric oxide synthase inhibition. Crit Care Med 1996; 24:558-565
45. Hart JL, Ledvina MA, Muldoon SM: Actions of diaspirin cross-linked hemoglobin on isolated rat and dog vessels. J Lab Clin Med 1997; 129:356-363
46. Resta TC, Walker BR, Eichinger MR, et al: Rate of NO scavenging alters effects of recombinant hemoglobin solutions on pulmonary vasoreactivity. J Appl Physiol 2002; 93:1327-1336
47. Rudolph AS, Sulpizio A, Hieble P, et al: Liposome encapsulation attenuates hemoglobin-induced vasoconstriction in rabbit arterial segments. J Appl Physiol 1997; 82: 1826-1835
48. Bone HG, Schenarts PJ, Booke M, et al: Oxalated pyridoxalated hemoglobin polyoxyethylene conjugate normalizes the hyperdynamic circulation in septic sheep. Crit Care Med 1997; 25:1010-1018
49. Gulati A, Singh R, Chung SM, et al: Role of endothelin-converting enzyme in the systemic hemodynamics and regional circulatory effects of proendothelin-1 (1-38) and diaspirin cross-linked hemoglobin in rats. J Lab Clin Med 1995; 126:559-570
50. Rohlfs RJ, Bruner E, Chiu A, et al: Arterial blood pressure responses to cell-free hemoglobin solutions and the reaction with nitric oxide. J Biol Chem 1998; 273: 12128-12134
51. Sakai H, Hara H, Yuasa M, et al: Molecular dimensions of Hb-based O(2) carriers determine constriction of resistance arteries and hypertension. Am J Physiol Heart Circ Physiol 2000; 279:H908-H915
52. Bouwer ST, Hoofd L, Kreuzer F: Diffusion coefficients of oxygen and hemoglobin measured by facilitated oxygen diffusion through hemoglobin solutions. Biochim Biophys Acta 1997; 1338:127-136
53. Nishide H, Chen XS, Tsuchida E: Facilitated oxygen transport with modified and encapsulated hemoglobins across non-flowing solution membrane. Artif Cells Blood Substit Immobil Biotechnol 1997; 25:335-346
54. Lindbom L, Tuma RF, Arfors KE: Influence of oxygen on perfused capillary density and capillary red cell velocity in rabbit skeletal muscle. Microvasc Res 1980; 19:197-208
55. McCarthy MR, Vandegriff KD, Winslow RM: The role of facilitated diffusion in oxygen transport by cell-free hemoglobins: Implications for the design of hemoglobin-based oxygen carriers. Biophys Chem 2001; 92: 103-117
56. Winslow RM, Gonzales A, Gonzales ML, et al: Vascular resistance and the efficacy of red cell substitutes in a rat hemorrhage model. J Appl Physiol 1998; 85:993-1003
57. Wettstein R, Tsai AG, Erni D, et al: Resuscitation with polyethylene glycol-modified human hemoglobin improves microcirculatory blood flow and tissue oxygenation after hemorrhagic shock in awake hamsters. Crit Care Med 2003; 31:1824-1830
58. Schultz SC, Hamilton IN, Malcolm DS: Use of base deficit to compare resuscitation with lactate Ringer's solution, hemacel, whole blood and diaspirin cross-linked hemoglobin following hemorrhage in rats. J Trauma 1993; 35:619-626
59. Siegel JH, Fabian M, Smith JA, et al: Use of recombinant hemoglobin solution in reversing lethal hemorrhagic hypovolemic oxygen debt shock. J Trauma 1997; 42: 199-212
60. Knudson MM, Lee S, Erickson V, et al: Tissue oxygen monitoring during hemorrhagic shock and resuscitation: A comparison of lactated Ringer's solution, Hypertonic saline dextran, and HBOC-201. J Trauma 2003; 54:242-252
61. Driessen B, Jahr JS, Lurie F, et al: Arterial oxygenation and oxygen delivery after hemoglobin-based oxygen carrier infusion in canine hypovolemic shock: A dose-response study. Crit Care Med 2003; 31:1771-1779
62. Driessen B, Jahr JS, Lurie F, et al: Effects of haemoglobin-based oxygen carrier hemoglobin glutamer-200 (bovine) on intestinal perfusion and oxygenation in a canine hypovolaemia model. Br J Anaesth 2001; 86: 683-692
63. McNeil CJ, Smith LD, Jenkins LD, et al: Hypotensive resuscitation using a polymerized bovine hemoglobin-based oxygen-carrying solution (HBOC-201) leads to reversal of anaerobic metabolism. J Trauma 2001; 50:1063-1075
64. Chappell JE, McBride WJ, Shackford SR: Diaspirin cross-linked hemoglobin resuscitation improves cerebral perfusion after head injury and shock. J Trauma 1996; 41: 781-788
65. Bowes MP, Burhop KE, Zivin JA: Diaspirin cross-linked hemoglobin improves neurological outcome folowing reversible but not irreversible CNS ischemia in rabbits. Stroke 1994; 25:2253-2257
66. Cole DJ, Schell RM, Drummond JC, et al: Focal cerebral ischemia in rats: Effect of hemodilution with α-α cross-linked hemoglobin on brain injury. Can J Neurol Sci 1993; 20:30-36
67. Chappell JE, Shackford SR, MacBride WJ: Effect of hemodilution with diaspirin cross-linked hemoglobin on intracranial pressure, cerebral perfusion pressure, and fluid requirements after head injury and shock. J Neurosurg 1997; 86:131-138
68. Lam C, Tyml K, Martin C, et al: Microvascular perfusion is impaired in a rat model of normotensive sepsis. J Clin Invest 1994; 94: 2077-2083
69. Sielenkämper AW, Chin-Yee IH, Martin C, et al: Diaspirin crosslinked hemoglobin imporves systemic oxygen uptake in oxygen-supply dependent septic rats. Am J Respir Crit Care Med 1997; 156:1066-1072
70. Creteur J, Zhang H, De Backer D, et al: Diaspirin cross-linked hemoglobin improves oxygen extraction capabilities in endotoxic shock. J Appl Physiol 2000; 89: 1437-1444
71. Wong HR, Carcillo JA, Burckart G, et al: Increased serum nitrite and nitrate concentrations in children with the sepsis syndrome. Crit Care Med 1995; 23:835-842
72. Gomez-Jimenez J, Salgado A, Mourelle M, et al: L-arginine: Nitric oxide pathway in endotoxemia and human septic shock. Crit Care Med 1995; 23:253-258
73. Szabo C: Alterations in nitric oxide production in various forms of circulatory shock. New Horiz 1995; 3:2-32
74. Vincent JL, Preiser JC, Zhang H: Blocking the effects of nitric oxide in septic shock. In: Role of Nitric Oxide in Septic Shock -Update in Intensive Care and Emergency Medicine. Vol. 24. Fink MP, Payen D (Eds). Berlin, Heidelberg, New York, Springer Verlag, 1995, pp 253-273
75. Kilbourn RG, Szabó C, Traber D: Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock: Lessons learned from experimental and clinical studies. Shock 1997; 7:235-246
76. Bone HG, Waurick R, Van Aken H, et al: Comparison of the hemodynamic effects of nitric oxide synthase inhibition and nitric oxide scavenging in endotoxemic sheep. Intensive Care Med 1998; 24:48-54
77. Matheson-Urbaitis B, Lu YS, Fronticelli C, et al: Renal and systemic-hemodynamic response to isovolemic exchange transfusion with hemoglobin cross-linked with bis (3, 5-dibromosalicyl) fumarate or albumin. J Lab Clin Med 1995; 126:250-260
78. Heneka MT, Löschmann PA, Osswald H: Polymerized hemoglobin restores cardiovascular and kidney function in endotoxin-induced shock in the rat. J Clin Invest 1997; 99:47-54
79. Neviere R, Sielenkamper A, Pitt M, et al: Diaspirin crosslinked hemoglobin prevents endotoxin induced myocardial contractile dysfunction in an isolated and perfused rat heart model. Abstr. Am J Respir Crit Care Med 1997; 155:A926
80. Cooper A, Ellis C, Lin HY, et al: Effect of diaspirin crosslinked hemoglobin (DCLHB) treatment on myocardial blood flow heterogeneity in septic sheep. Abstr. Am J Respir Crit Care Med 1997; 155:A926
81. Biro GP, Beresford-Kroeger D: The effect of hemodilution with stroma-free hemoglobin and dextran on collateral perfusion of ischemic myocardium in the dog. Am Heart J 1980; 99:64-65
82. MacKenzie JE, Cost EA, Scanding DM, et al: Effects of diaspirin cross-linked hemoglobin during coronary angioplasty bypass in swine. Cardiovasc Res 1994; 28:1188-1192
83. Cole DJ, Schell RM, Drummond JC, et al: Focal cerebral ischemia in rats: Effect of hypervolemic hemodilution with diaspirin cross-linked hemoglobin versus albumin on brain injury and edema. Anesthesiology 1993; 78:335-342
84. Rebel A, Ulatowski JA, Joung K, et al: Regional cerebral blood flow in cats with cross-linked hemoglobin transfusion during focal cerebral ischemia. Am J Physiol Heart Circ Physiol 2002; 282:H832-H841
85. Habler O, Kleen M, Pape A, et al: Diaspirin-crosslinked hemoglobin reduces mortality of severe hemorrhagic shock in pigs with critical coronary stenosis. Crit Care Med 2000; 28:1889-1898
86. Lee JT, Arenholz DH, Nelson RD, et al: Mechanisms of the adjuvant effect of hemoglobin in experimental peritonitis V: The significance of the co-ordinated iron component. Surgery 1979; 86:41-47
87. Kim YM, Yamazaki I, Piette LH: The effect of haemoglobin, hematin and iron on neutrophil inactivation in superoxide generating systems. Arch Biochem Biophys 1994; 309:308-314
88. Griffiths E, Cortes A, Gilbert N, et al: Haemoglobin-based blood substitutes and sepsis. Lancet 1995; 345:158-160
89. Su D, Roth RI, Levin J: Hemoglobin infusion augments the tumor necrosis factor response to bacterial endotoxin (lipopolysaccharide) in mice. Crit Care Med 1999; 27:771-778
90. Sherry BA, Alava G, Tracey KJ, et al: Malaria-specific metabolite hemozoin mediates the release of several potent endogenous pyrogens (TNF, MIP-1α and MIP-1β) in vitro, and altered thermoregulation in vivo. J Inflamm 1995; 45:85-96
91. McFaul SJ, Bowman PD, Villa VM, et al: Hemoglobin stimulates mononuclear cells to release interleukin-8 and tumor necrosis factor α. Blood 1994; 84:3175-3181
92. Carrillo EH, Gordon LE, Richardson JD, et al: Free hemoglobin enhances tumor necrosis factor-alpha production in isolated human monocytes. J Trauma 2002; 52: 449-452
93. Rabinovici R, Rudolph AS, Vernick J, et al: Lyophilized liposome encapsulated hemoglobin: Evaluation of hemodynamic, biochemical, and hematologic responses. Crit Care Med 1994; 22:480-485
94. Rudolph AS, Cliff R, Kwasiborski V, et al: Liposome-encapsulated hemoglobin modulates lipopolysaccharide-induced tumor necrosis factor-α production in mice. Crit Care Med 1997; 25:460-468
95. Misra HP, Fridovich I: The generation of superoxide radical during the autooxidation of hemoglobin. J Biol Chem 1972; 247: 6960-6962
96. Faassen AE, Sundby SR, Panter SS, et al: Hemoglobin: a lifesaver and an oxidant: How to tip the balance. Biomater Artif Cells Artif Organs 1988; 16:93-104
97. O'Hara JF Jr, Colburn WA, Tetzlaff JE, et al: Hemoglobin and methemoglobin concentrations after large-dose infusions of diaspirin cross-linked hemoglobin. Anesth Analg 2001; 92:44-48
98. Szebeni J, Winterbourn CC, Carrell RW: Oxidative interactions between haemoglobin and membrane lipid: A liposome model. Biochem J 1984; 220:685-692
99. Sadrzadeh SM, Anderson DK, Panter SS, et al: Hemoglobin potentiates central nervous system damage. J Clin Invest 1987; 79: 662-664
100. Razack S, D'Agnillo F, Chang TM: Crosslinked hemoglobin-superoxide dismutase-catalase scavenges free radicals in a rat model of intestinal ischemia-reperfusion injury. Artif Cells Blood Substit Immobil Biotechnol 1997; 25:181-192
101. Powanda DD, Chang TM: Cross-linked polyhemoglobin-superoxide dismutase-catalase supplies oxygen without causing blood-brain barrier disruption or brain edema in a rat model of transient global brain ischemia-reperfusion. Artif Cells Blood Substit Immobil Biotechnol 2002; 30:23-37
102. Baldwin AL, Wiley EB, Alayash AI: Comparison of effects of two hemoglobin-based O(2) carriers on intestinal integrity and microvascular leakage. Am J Physiol Heart Circ Physiol 2002; 283:H1292-H1301
103. Olsen SO, Tang DB, Jackson MR, et al: Enhancement of platelet deposition by cross-linked hemoglobin in a rat carotid endarterectomy model. Circulation 1996; 93: 327-332
104. Coins B, Phillips WT, Klipper R, et al: Role of complement in rats injected with liposome-encapsulated hemoglobin. J Surg Res 1997; 68:99-105
105. Toussaint M, Latger-Cannard V, Caron A, et al: Hemoglobin-based oxygen carriers do not alter platelet functions: Study of three chemically modified hemoglobin solutions. Intensive Care Med 2003; 29:62-68
106. Hughes GS Jr, Francom SF, Antal EJ, et al: Effects of a novel hemoglobin-based oxygen carrier on percent oxygen saturation as determined with arterial blood gas analysis and pulse oximetry. Ann Emerg Med 1996; 27:164-168
107. Lurie F, Driessen B, Jahr JS, et al: Validity of arterial and mixed venous oxygen saturation measurements in a canine hemorrhage model after resuscitation with varying concentrations of hemoglobin-based oxygen carrier. Anesth Analg 2003; 96: 46-50
108. Carmichael FJ, Ali AC, Campbell JA, et al: A phase I study of oxidized raffinose cross-linked human hemoglobin. Crit Care Med 2000; 28:2283-2292
109. Swan SK, Halstenson CE, Collins AJ, et al: Pharmacologic profile of diaspirin cross-linked hemoglobin in hemodialysis patients. Am J Kidney Dis 1995; 26:918-923
110. Gould SA, Moore EE, Hoyt DB, et al: The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable. J Am Coll Surg 2002; 195: 445-452
111. Sloan EP, Koenigsberg M, Gens D, et al: Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: A randomized controlled efficacy trial J A M A 1999; 282: 1857-1864
112. Kerner T, Ahlers O, Veit S, et al: DCL-Hb for trauma patients with severe hemorrhagic shock: The European "On-Scene" Multicenter Study. Intensive Care Med 2003; 29: 378-385
113. Saxena R, Wijnhoud AD, Carton H, et al: Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke. Stroke 1999; 30:993-996
114. Tanaka J, Takino H, Malchesky PS, et al: Does oxygen supply improve graft viability in liver preservation? Biomater Artif Cells Immobilization Biotechnol 1992; 20: 545-548
115. Liu H, Agishi T, Kawai T, et al: Evaluation of a pyridoxylated hemoglobin polyoxyethylene conjugate solution as a perfusate for small intestine preservation. Biomater Artif Cells Immobilization Biotechnol 1992; 20: 557-561
116. Pristoupil TI, Sterbikova J, Vrana M, et al: Heart protection by cardioplegic solutions containing oxyhemoglobin pretreated by carbontetrachloride and freeze-drying with sucrose. Biomater Artif Cells Immobilization Biotechnol 1992; 20:709-720
117. Liu H, Agishi T, Suga H, et al: The effect of total blood exchange with PHP solution on cardiac xenotransplantation. Artif Organs 1995; 19:324-327
118. Teicher BA, Dupuis NP, Emi Y, et al: Increased efficacy of chemo-and radiotherapy by a hemoglobin solution in the 9L gliosarcoma. In Vivo 1995; 9:11-18